Recombinant RNase Inhibitor, HQ

Description

Recombinant RNase Inhibitor, HQ high quality contains a mutation in a cysteine residue that is very sensitive to oxidation, making it highly stable in enzymatic reactions requiring low DTT concentrations. It inhibits RNase A activity through the formation of a 1:1 complex in a reversible reaction. It is not effective against RNase H activity. Recombinant RNase Inhibitor, HQ has equivalent enzyme performance as Recombinant RNase Inhibitor ver.2.0 but has been produced with stricter quality standards and is supplied in a higher volume. It is intended for use in the preparation of active pharmaceutical ingredients APIs for non-clinical trials, as well as for the process development of drug manufacturing under good manufacturing practice GMP regulations. Our products are to be used forResearch Use Only. They may not be used for any other purpose, including, but not limited to, use in humans, therapeutic or diagnostic use, or commercial use of any kind. Our products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products or to provide a service to third parties without our prior written approval.